Melanoma complicating treatment with natalizumab for multiple sclerosis

N Engl J Med. 2008 Feb 7;358(6):647-8. doi: 10.1056/NEJMc0706103.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Female
  • Humans
  • Integrin alpha4 / immunology*
  • Melanoma / chemically induced*
  • Melanoma / immunology
  • Middle Aged
  • Multiple Sclerosis / drug therapy*
  • Natalizumab
  • Retinal Neoplasms / chemically induced*
  • Skin Neoplasms / chemically induced*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Natalizumab
  • Integrin alpha4